Astria Therapeutics, Inc.
ATXS
$5.86
-$0.03-0.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.04M | -94.26M | -100.04M | -93.24M | -81.63M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.35M | 8.51M | 8.42M | 8.22M | 7.77M |
| Change in Net Operating Assets | 2.56M | 4.54M | -2.46M | 4.64M | -420.00K |
| Cash from Operations | -96.14M | -81.21M | -94.09M | -80.38M | -74.29M |
| Capital Expenditure | -325.00K | -325.00K | -341.00K | -325.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.72M | -191.54M | -189.82M | -196.03M | -186.15M |
| Cash from Investing | -37.05M | -191.86M | -190.16M | -196.35M | -186.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.40M | 157.20M | 245.18M | 229.99M | 230.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.40M | 157.20M | 245.18M | 229.99M | 230.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.79M | -115.87M | -39.07M | -46.75M | -30.29M |